DirectoryMix Web Resources » Article Details

Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug - Read More

Date Added: July 19, 2008 05:40:02 AM
Meditrina Pharmaceuticals, Inc. announced the approval of its second investigational new drug (IND) application for a Phase IIb dose ranging clinical trial to study MPI-676, the Company's aromatase inhibitor (AI), in combination with estrogen and progestin for the treatment of endometriosis.

Category: Health » Procedures and Therapies


No comments are posted yet


 
Name:*
Email:*
Website:  (optional)
Comment:*
(html and bb codes are filtered and not allowed)

Do the math:*CAPTCHA - Do The Math
 

Related Articles

A woman’s struggle to lose weight

MANILA, Philippines—Even before the unkind words and scrutinizing looks Lani Ayala receives from people around her, the 38-year-old real estate and property leasing officer from Davao City already knew she really had to take control of her life.

Hepatitis C

Government agencies, universities and corporations frequently enroll patients in studies designed to test the effectiveness of new drugs, procedures and medical devices.

Sixty Plus: Make a case for 'slow medicine'

Dennis McCullough, geriatrician and family physician for 30 years, currently practicing at Kendal at Hanover Continuing Care Community and Dartmouth Medical School, makes a case for "slow medicine" in his new book "My Mother, Your Mother: Embracing 'S

Tensions grow over cancer treatments

The new generation of cancer medicines raises delicate and potentially explosive issues for the government’s medicines advisory body. In the past decade, the National Institute for Health and Clinical Excellence has recommended an overwhelming majority

Donating life

NILES - Potential donors are the focus in a second look at this year's Relay for Life event taking place at Niles High School Saturday and Sunday July 26 and 27.